Psychology & Psychiatry

Study casts doubt on ketamine nasal sprays for depression

Researchers from the Black Dog Institute and UNSW Sydney have questioned the efficacy and safety of intranasal ketamine for depression, with their pilot trial stopped early due to poor side effects in patients.

Psychology & Psychiatry

Guidelines updated for managing and ID'ing adolescent depression

(HealthDay)—Clinical practice guidelines have been updated to assist primary care (PC) physicians in the screening, treatment, and management of adolescent depression in youth aged 10 to 21 years. The details of the updates ...

page 9 from 19